National Standardization of ZAP-70 Determination by Flow Cytometry: The French Experience
|
|
- Kevin Lynch
- 6 years ago
- Views:
Transcription
1 Cytometry Part B (Clinical Cytometry) 72B: (2007) National Standardization of ZAP-70 Determination by Flow Cytometry: The French Experience Magali Le Garff-Tavernier, 1 Michel Ticchioni, 2 Martine Brissard, 1 Céline Salmon, 3 Sophie Raynaud, 4 Frédéric Davi, 1 Alain Bernard, 2 Hélène Merle-Béral, 1 Florence Ajchenbaum-Cymbalista, 3 and Rémi Letestu 3 * 1 Hematology Biology Department, CHU Pitié Salpêtrière, Paris, France 2 Immunology Biology Department, Hôpital de l Archet, CHU Nice, Nice, France 3 Hematology Biology Department, CHU Avicenne, Bobigny, France 4 Hematology Biology Department, Hôpital Pasteur, CHU Nice, Nice, France Background: ZAP-70, after being considered as a potential surrogate for VH mutational status, has seen its own prognostic value emerge. We aimed at standardizing a simple, fast, and reproducible flow cytometry method. Methods: AntiZAP-70 antibody 2F3.2 was used with indirect labeling and secondary anti-igg2a antibody. The reference values for the expression of the results were determined on 45 normal blood samples. ZAP-70 protein expression was investigated in 192 CLL samples. The indirect technique was compared with FITC-conjugated 2F3.2 clone, and with clone 1E7.2-FITC, -PE or -AlexaFluor 488. Results: Using FITC or PE-conjugated antibodies, 2F3.2 and 1E7.2 clones allowed a much less adequate discrimination between positive and negative cells and discordant cases were most likely true negative cases. Using the AlexaFluor 488 conjugated 1E7.2 clone, the discordant cases were mostly negative with the conjugated antibody and positive with the 2F3.2 clone but Western blotting or RNA microarray confirmed discordant cases were false negative with the conjugated antibody. Subsequently, recommendations were used by 13 centers participating in an interlaboratory quality control protocol. The use of MFI ratio appeared to be more reliable. Conclusions: Results suggested that slight differences in the procedure had little impact on the interpretation in characteristic cases; however, careful interpretation was required for values close to threshold. q 2006 International Society for Analytical Cytology Key terms: ZAP-70; flow cytometry; CLL; harmonization Chronic lymphocytic leukemia (CLL) is the most frequent lymphoproliferative disorder in Western countries. As new therapeutic approaches emerged, the precise evaluation of the prognosis for each patient is required for decision making. In the past few years, numerous prognostic factors were evaluated and the percentage of homology with germline sequence of CLL IgHV gene rearrangement appeared to be the gold standard for the prediction of the outcome (1). Genomic studies using microarray approaches demonstrated the unity of the disease irrespective of IgHV mutational status (2,3). Approximately 200 genes were found differentially expressed between mutated and unmutated groups and among these genes, a judicious selection of few of them allows to accurately predict the mutational status of IgHV genes. Among them, the gene encoding 70 kda Zeta Associated Protein (ZAP-70) was unexpectedly found expressed at a significantly higher level in the group of unmutated cases. Since the evaluation of ZAP-70 expression was supposed to be easier and less expensive and time consuming than the determination of IgHV somatic mutations, ZAP-70 status was proposed as a surrogate for mutational status (4). Moreover, later studies evidenced that ZAP-70 had its own prognostic value (5,6), even if the concordance with mutational status has reduced to around 80% of cases (7). Grant sponsor: PSTIC 2003, Health Department, Government of France. *Correspondence to: R. Letestu, Hematology Biology Department, CHU Avicenne, 125 rue de Stalingrad, Bobigny, France. remi.letestu@avc.aphp.fr Received 30 August 2006; Accepted 30 August 2006 Published online 13 October 2006 in Wiley InterScience (www. interscience.wiley.com). DOI: /cyto.b q 2006 International Society for Analytical Cytology
2 104 LE GARFF-TAVERNIER ET AL. Different techniques may be used to explore ZAP-70 expression in CLL cells: at the DNA level by studying promoter methylation (8), at the RNA level using PCR methods (9,10), or at the protein level (4,5,11). As different lymphocyte subsets normally express ZAP-70 (12), the technique used has to discriminate between ZAP-70 expression in CLL cells and physiologic expression. Most techniques are sensitive to the presence in the sample of T or NK cells. PCR and Western blot (WB) require a selection of leukemic cells whereas methylation study tolerates a higher level of contamination. Therefore, flow cytometry appeared a promising method allowing to measure ZAP-70 expression in different lymphocytes subsets defined on the basis of their expression of selected membrane markers. In this collaborative work, we aimed at developing a simple, fast, and reproducible flow cytometry approach for ZAP-70 determination in CLL. PATIENTS AND METHODS Cell Samples Three institutions participated in the study and 13 centers were involved in interlaboratory quality control. Peripheral blood was obtained from 192 untreated CLL patients followed in these centers and from 45 normal subjects after informed consent. Purification of B Cells Purification of B cells was performed by either negative selection using RosetteSep 1 (ref. no.15024, StemCell Technologies, Grenoble, France) or positive selection on CD19 expression using LS column 1 (ref. no , Myltenyi Biotec, Paris, France). The two techniques gave comparable results in terms of purity of the sample (96 98% of CD19 positive cells were collected). The RosetteSep technique is easy, fast, does not require columns and magnets, and could be run in parallel with Ficoll. The drawback is the necessity to use fresh whole blood samples with the presence of red blood cells, making it unsuitable for conserved frozen samples. Western Blot Western blotting was conducted on purified B cells. Briefly, after standard lysis, migration on polyacrylamide gel and transfer on nitrocellulose membrane, the 2F3.2 clone (Upstate 1 ) anti-zap-70 antibody was used at 1/1000e dilution. ZAP-70 protein was revealed using a rat antimouse HRP-conjugated secondary antibody and ECL TM Western blotting detection reagent (ref. no. RPN2209, Amersham- Biosciences, Saclay, France) as substrate. Flow Cytometry Determination of ZAP-70 expression was performed either on freshly isolated mononuclear cells by Ficoll-Hypaque density gradient or on DMSO frozen cells. Different procedures were described with regard to ZAP-70 protein labeling with respect to consensual minimal recommendations. In an attempt on homogeneity, the use of a commercial kit for fixation and permeabilization was recommended. The Fix and perm 1 kit from Caltag was selected. As the equipment was different from one center to another, the choice of the fluorochrome remained open. In contrast, the membrane markers were imposed including antibodies directed against CD19 as B-cell marker, CD3 and CD56. The addition of an anti-cd5 antibody was recommended to discriminate between residual normal B-lymphocytes and CLL cells. This combination was supposed to allow the discrimination of B-CLL cells, residual T-lymphocytes and NK cells, and normal residual B cells. Two different clones of anti-zap-70 antibodies were tested. The following purified or directly conjugated antibodies were purchased from different manufacturers: FITC conjugated clone 2F3.2 (Upstate); PE conjugated clone 1E7.2 (ebioscience 1 ); PE conjugated clone 1E7.2 (Tebu Caltag 1 ); and Alexa 488 conjugated clone 1E7.2 (Tebu Caltag). When purified 2F3.2 clone was used, the secondary antibody was FITC conjugated and different reagents were tested as describe below. The mode of expression of results is crucial for correct interpretation of the analysis. We evaluated thresholds related to isotypic control and to ZAP-70 expression in T cells as determined by Crespo et al. (4). In order to include an internal control we considered mean fluorescence intensity (MFI) in T-lymphocytes (T-Ly) and CLL cells. Cut-offs were defined as described in Table 1. It was recommended to acquire on the flow cytometer at least 1,000 T-Ly, and as many CD5 negative B-lymphocytes (B-Ly) as possible. Interlaboratory Quality Control Scheme The recommendations described above were evaluated in 13 centers participating in CLL studies. For the purpose of standardization, the use of commercial reagents for fixation and permeabilization was decided. For ZAP-70 labeling, as we obtained discordant results with conjugated anti ZAP-70 antibodies, the use of indirect technique was preferred. The FITC conjugated secondary antibody could be either anti-igg or specific anti-igg2a. Four different CLL samples were selected on the basis of their characteristic pattern of ZAP-70 expression. DMSO frozen cells were sent to the participating centers in dry ice and processed according to the minimal recommendations. Results were reported according to two guidelines: percentage of CLL cells above a threshold set on the expression of ZAP-70 on T lymphocytes (%/T-Ly) and a MFI ratio ¼ MFI ZAP-70 T lymphocytes/mfi ZAP-70 CLL cells (T-Ly/CLL ratio). Parameter %/T-Ly T-Ly/CLL Table 1 Expression of the Results in Blood Samples Positivity Description threshold % of Zap-70 positive B-CLL cells according to ZAP-70 expression in T-Ly 20% Inconclusive results ZAP-70 mean fluorescence intensity T-Ly/B-CLL ratio <4 4-5
3 NATIONAL STANDARDIZATION OF ZAP-70 DETERMINATION BY FLOW CYTOMETRY: THE FRENCH EXPERIENCE negative and 17 positive cases studied (Fig. 2). Therefore, both antibodies are suitable, but the specificity of anti-igg2a is of interest to alleviate the staining protocol and to avoid the risk of losing formalin sensitive antigens. FIG. 1. Western blot analysis. Comparison of flow cytometry and western blot data in four representative cases. In the case 1, Western blot was interpreted as a carryover of the extract by residual T lymphocytes. RESULTS The expression of ZAP-70 protein was investigated in 192 samples of CLL patients from three different institutions. Validation of Flow Cytometry Results by Western Blotting We compared results obtained by WB on purified B cells with those obtained by flow cytometry on 50 cases and a good concordance was observed (Fig. 1). Twentyone cases were found ZAP-70 negative by either WB or cytometry; 23 were ZAP-70 positive by both techniques. None was found positive by cytometry and negative by WB, but 6 cases appeared positive by WB only, and considered negative in cytometry. Positivity of WB in these cases might be interpreted as contamination by T cells in the purified B cell extracts used for WB. Choice of Secondary Antibody ZAP-70 expression was compared in 21 CLL patients and one normal B cell control by indirect labeling with either anti-igg or anti-igg2a secondary antibody. There was a good correlation between the results obtained with either one and no discordant result was observed among the Threshold of Positivity Was Determined on a Series of Normal Blood Samples Using a specific anti-igg2a secondary antibody, we investigated a series of 45 normal blood samples. We aimed at establishing reference values for the different modes of expression of the results (Table 1). The use of a threshold related to isotypic control was clearly not optimal. As the results were highly variable from one sample to another (CV ¼ 93%), this mode of expression was not further considered. We considered a threshold relative to T-Ly as previously described for CLL. Interestingly, although variable among different healthy volunteers, a threshold relative to ZAP-70 expression in T cells at 20% for positivity as determined by Crespo et al. (4) was applicable to normal blood samples. As we observed a significant variability of ZAP-70 analysis, we also evaluated the use of MFI ratio as a new mode of expression of the results. Considering the T-Ly/ B-Ly MFI ratio, the results were similar whether normal B-lymphocytes were CD5þ or CD5. Based on the mean of T-Ly/normal B-Ly ratio, a positivity threshold at 4 was established. Choice of the Anti ZAP-70 Antibody Comparison of purified versus FITC conjugated 2F3.2 clone (Upstate). Eighty-three patients have been tested with both techniques. The results were discordant in up to 36% (30/83 pts) of cases, mostly because cases that were negative by the indirect technique appeared positive with the conjugated antibody. Figure 3 (panels A and B) illustrates the discrepancy between both techniques. Using the conjugated antibody allowed a much less adequate FIG. 2. Choice of the secondary antibody. ZAP-70 expression was studied in 22 samples using either anti-igg or specific anti-igg2a secondary antibodies. There was a good coefficient of correlation between the two techniques independent of the mode of expression of the results used. Panel A shows results as % relative to T-Ly and panel B as T-Ly/B-CLL ZAP-70 MFI ratio.
4 106 LE GARFF-TAVERNIER ET AL. discrimination between positive and negative cells. Moreover, the distribution of T cells was clearly overlapping on negative cells in both negative CLL cases and normal blood samples. Therefore, we concluded that the discordant cases were most likely true negative cases that appeared mistakenly positive with conjugated antibody. Comparison of purified 2F3.2 clone with fluorochrome conjugated 1E7.2 clone. Two other commercially available conjugated antibodies derived from the 1E7.2 clone have also been tested. These antibodies were either PE-conjugated (ebioscience and Caltag 1 ) or Alexa- Fluor 488-conjugated (Caltag). PE-conjugated 1E7.2 was tested in 54 cases and compared with 2F3.2 clone using indirect labeling. On the 9 cases tested simultaneously with both PE-conjugated antibodies, we obtained similar results with a heterogeneous labeling on the T cell population that was even more divergent with the ebioscience antibody. Therefore, only Caltag antibody was used for further comparison. We observed 17/54 discordant cases (31%) among which in most cases ZAP-70 expression was interpreted as negative with 2F3.2 clone and positive with PE-conjugated 1E7.2 antibody. The analysis of the graphs led to a similar conclusion as in the previous experiment with FITC conjugated 2F3.2 clone. Besides a decrease in ZAP-70 fluorescence intensity, we suspected that the heterogeneous labeling of the T cells might also hamper the determination of the position of the positivity threshold (Fig. 3, panels A and C). This pattern of ZAP-70 expression being observed in normal blood samples as well, we concluded that most of the discordant cases were misinterpreted as false positive. Finally we compared purified 2F3.2 clone with Alexa488- conjugated 1E7.2 antibody in 56 independent samples. In contrast with the previous directly conjugated antibody tested, the discordant cases were mostly negative with the conjugated antibody and positive with the 2F3.2 clone. It was not possible to reinvestigate all the 14 discordant cases but examination of 6/14 by either WB or RNA microarray confirmed the presence of ZAP-70 expression. Therefore these cases were interpreted as false negative. FIG. 3. Comparison between indirect labeling and two directly conjugated antibodies in ZAP-70 negative cases. Representative examples of discordant data are presented. ZAP-70 negative CLL cells were labeled as described in Patients and Methods by indirect method using unlabeled 2F3.2 mab (panel A) or by direct staining using either FITC-conjugated 2F3.2 (panel B) or PE-conjugated 1E7.2 mab (panel C). ZAP-70 expression is shown on CLL cells (black histogram) and T cells (grey histogram) or in cells labeled with an irrelevant isotype matched antibody (opened histogram). The M1 marker returns the percentage of ZAP-70 positive CLL cells and is set according to ZAP-70 expression in T cells. Note that the different histograms are overlayed on the same figure. Technical Consensus and Validation The results of the different experiments allowed establishment of minimal recommendations for ZAP-70 evaluation by flow cytometry that were evaluated in 13 centers participating in a national multicentric protocol. This study was designed as an interlaboratory quality control. Although not strictly identical from one center to another, the procedures used allowed the 13 participating centers to give the same interpretations in 3 samples out of 4 (1 positive and 2 negative). In all cases, %/T-Ly showed a higher coefficient of variation as compared with T-Ly/ CLL ratio. The fourth sample was selected for the difficulty to draw a conclusion on its level of ZAP-70 expression. As expected, discordant interpretations were reported. The results were deduced as negative in 5 centers (ranging from 11 to 19% of positive cells relative to T-Ly) and positive (ranging from 30 to 92% of positive cells relative to T-Ly) in the 8 remaining centers. The sample was tested using an alternative method and confirmed negative. As this variation might be the consequence of the freezing procedure, we analyzed the impact of cryopreservation on ZAP-70 detection. We compared fresh and frozen samples from 17 CLL patients (5 positive, 12 negative) and 3 normal controls. In normal and patient samples, the conclusions on ZAP-70 status were identical before and after cryopreservation. These preliminary data need to be confirmed on a larger series of samples to determine if the positivity threshold should be refined depending on the type of sample (fresh or frozen) investigated. DISCUSSION The aim of the first step of this study was to validate ZAP- 70 quantification technique. At the beginning of our study, only one flow cytometry method had been published (4)
5 NATIONAL STANDARDIZATION OF ZAP-70 DETERMINATION BY FLOW CYTOMETRY: THE FRENCH EXPERIENCE based on the use of 2F3.2 anti-zap-70 antibody and indirect labeling. First we aimed at validating this approach in our hands. For this purpose, we decided to systematically compare results obtained by Western blot on purified B cells with those obtained by flow cytometry. The concordance was good with only 6 cases appearing positive by WB and negative in cytometry. These results were interpreted as contamination by T cells in the purified B cell extracts used for Western blot. Depending on the antigens targeted and the antibodies used, the detection of B-cell markers after fixation procedure may be impaired. However, as the indirect technique was preferred, intracytoplasmic staining was supposed to precede membrane labeling. In order to simplify the protocol, the use of a specific anti-igg2a secondary antibody allowed membrane staining prior to fixation provided only antibodies of IgG1 isotype are used at this step are tested and found of interest to simplify the staining protocol. We then aimed at establishing reference values for the different modes of expression of the results in a series of 45 normal blood samples. Interestingly, a threshold reated to isotypic control was found unsuitable but a threshold relative to ZAP-70 expression in T cells at 20% as determined by Crespo et al. (4) was applicable to these normal blood samples. In order to include an internal control in the interpretation of the results and to minimize the interoperator variability in subsequent multicentric applications, we also considered the use of MFI ratio for subsequent studies. As intracellular labeling using an indirect method is time consuming, when available, fluorochrome conjugated antibodies are more adapted to routine use. Therefore, the indirect technique was compared with different directly conjugated antibodies. Using FITC-conjugated 2F3.2 and PEconjugated 1E7.2 antibodies allowed a much less adequate discrimination between positive and negative cells with a distribution of T cells clearly overlapping on negative cells in both negative CLL cases. Therefore, it seems that the *30% discordant cases we found were most likely true negative cases that appeared mistakenly positive with the conjugated antibody. This conclusion was reinforced by the observation of similar results when the conjugated antibodies were tested on normal blood samples. Either the size of the PE fluorochrome or the particular subcellular localization of ZAP-70 protein could be involved in the impaired staining observed with conjugated antibodies. In any case, a problem with fluorochrome conjugation cannot be ruled out. In contrast, using the Alexa 488 conjugated 1E7.2 clone, the discordant cases were mostly negative with the conjugated antibody and positive with the 2F3.2 clone. WB or RNA microarray confirmed that most of these latter discordant cases should be considered as false negative with the conjugated antibody. These results raised the question of the sensitivity of this antibody. Moreover, the immunogenic peptide used to raise 1E7.2 clone spans the tyrosine Y292, which is an important functional site. However little is known regarding the impact of Y292 phosphorylation and Cbl interactions on 1E7.2 binding ability in CLL cells. 107 Minimal recommendations from this preliminary study were subsequently used in 13 participating centers involved in CLL studies. A multicentric interlaboratory quality control was organized, which raised different issues and comments. Overall, attempts to standardize procedures gave encouraging results since no discordant conclusions were observed in patients with a characteristic pattern of ZAP-70 expression. When interpretation is more complex, additional interpretation guidelines (such as combining percentage and ratio) might be required. However, it should be kept in mind that distribution of ZAP-70 levels of expression follows a continuum and that binary interpretation (i.e. positive or negative) might be inappropriate. The use of MFI ratio appeared less variable as compared with percentage of positive cells but required also to establish normal values on normal control samples. Whether combining both methods improves the standardization is currently under evaluation on a larger series of patients. In all cases we recommend providing the physician with both the raw data and an interpretation of the analysis. In conclusion, in this study, as part of a French National Protocol proposed by the Health Department of the Government, we reached a technical consensus on different features of the determination of ZAP-70 expression by flow cytometry. Pre-analytical, analytical and interpretation issues were considered and led to recommendations for standardization of the technique. Our method was also tested and validated in a multicentric trial. The results suggested that slight differences in the procedures have little impact on the interpretation in characteristic cases. However, careful interpretation is required for values close to the threshold. ACKNOWLEDGMENTS We acknowledge Drs. Christine Arnoulet, Lucile Baseggio, Michel Degenne, Franck Genevieve, Marie-Christine Jacob, Marc Maynadie, Jean-Yves Perrot, Anne Plonquet Stéphanie Poulain, and Véronique Salaün for their participation in the interlaboratory quality control. We are grateful to Tebu-Caltag, ebioscience, and Upstate laboratories for providing us with some of the reagents used in this study. LITERATURE CITED 1. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94: Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla- Favera R. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194: Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194: Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:
6 108 LE GARFF-TAVERNIER ET AL. 5. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Klipps TJ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351: Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19: Krober A, Bloehdorn J, Hafner S, Buhler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Litcher P, Dohner H, Stilgenbauer S. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 2006;24: Corcoran M, Parker A, Orchard J, Davis Z, Wirtz M, Schmitz OJ, Oscier D. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005;90: DurigJ,NuckelH,CremerM,FuhrerA,HalfmeyerK,FandreyJ, Moroy T, Klein-Hitpass L, Duhrsen U. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003;17: Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD. ZAP-70 mrna quantification in B-cell chronic lymphocytic leukaemia. Eur J Haematol 2006;76: Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363: Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, Clark EA, Weiss A. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994;152:
ZAP-70 by Flow Cytometry: A Comparison of Different Antibodies, Anticoagulants, and Methods of Analysis
Cytometry Part B (Clinical Cytometry) 70B:235 241 (2006) ZAP-70 by Flow Cytometry: A Comparison of Different Antibodies, Anticoagulants, and Methods of Analysis O. G. Best, R. E. Ibbotson, A. E. Parker,
More informationModification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA Vol. 43, No. 1, 2005 pp. 19-23 Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia Agnieszka Bojarska-Junak
More informationKey terms: B-cell chronic lymphocytic leukemia (B-CLL); zeta-chain associated protein 70 (ZAP-70); flow cytometry
Cytometry Part B (Clinical Cytometry) 70B:293 301 (2006) Comparison of Methods for Determining Zeta-Chain Associated Protein 70 (ZAP-70) Expression in Patients with B-Cell Chronic Lymphocytic Leukemia
More informationAn Optimized Whole Blood Method for Flow Cytometric Measurement of ZAP-70 Protein Expression in Chronic Lymphocytic Leukemia
Cytometry Part B (Clinical Cytometry) 70B:259 269 (2006) An Optimized Whole Blood Method for Flow Cytometric Measurement of ZAP-70 Protein Expression in Chronic Lymphocytic Leukemia T. Vincent Shankey,
More informationSANTA CRUZ BIOTECHNOLOGY, INC.
TECHNICAL SERVICE GUIDE: Western Blotting 2. What size bands were expected and what size bands were detected? 3. Was the blot blank or was a dark background or non-specific bands seen? 4. Did this same
More informationAPC Anti-Human FoxP3 Transcription Factor Staining
APC Anti-Human FoxP3 Transcription Factor Staining Catalog Kit Number: 20-4770-KIT Kit Components APC Anti-Human Foxp3 with Isotype Control (TBhP3, TBhISO)... Cat.No. 20-4773- T025... Size 25 tests (Page
More informationChallenges for Flow Cytometry in Regulated Bioanalysis
Challenges for Flow Cytometry in Regulated Bioanalysis Minesh Patel Merck Millipore Discovery & Development Solutions. Oxford, UK. Overview Flow cytometry principles Current uses and regulatory environments
More informationCytomics in Action: Cytokine Network Cytometry
Cytomics in Action: Cytokine Network Cytometry Jonni S. Moore, Ph.D. Director, Clinical and Research Flow Cytometry and PathBioResource Associate Professor of Pathology & Laboratory Medicine University
More informationBD IMag. Streptavidin Particles Plus - DM. Technical Data Sheet. Product Information
Technical Data Sheet Streptavidin Particles Plus - DM Product Information Material Number: Size: Storage Buffer: 557812 5 ml Aqueous buffered solution containing BSA and 0.09% sodium azide. Description
More informationThe analysis of L-selectin expression intensity (CD62L) on B-lymphocytes in B-cell chronic lymphocytic leukemia cells (B-CLL)
Experimental immunology The analysis of L-selectin expression intensity (CD62L) on B-lymphocytes in B-cell chronic lymphocytic leukemia cells (B-CLL) JOANNA KOPEÆ-SZLÊZAK 1, URSZULA PODSTAWKA 1, LECH KONOPKA
More informationPrinciples of Multicolor Panel Design BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.
1 Principles of Multicolor Panel Design 2 Common Multicolor Applications Intracellular cytokine staining Regulatory T cells (Tregs) Protein phosphorylation (BD Phosflow) Leukemia and lymphoma phenotyping
More informationPrinciples of Immunophenotyping
Principles of Immunophenotyping % of Cell types? Immune activation? Changes based on health state? Moving from a heterogeneous population of blood cells to identifying the presence and proportion of different
More informationSolutions for Your Research
Solutions for Your Research Custom Antibody Services Polyclonal Monoclonal The service we offer is very complete starting from rabbits, mice and rats. The different formats provided by Primm depend on
More informationUnmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity
Research article Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity Maxime Hervé, 1 Kai Xu, 1 Yen-Shing Ng,
More informationChallenges in receptor occupancy determination assays by flow cytometry in drug development
Challenges in receptor occupancy determination assays by flow cytometry in drug development DATE 17 November 2016 PRESENTED BY Martine Broekema, Ph.D. Associated Director of Bioanalytical Sciences Large
More informationTechnical Bulletin. Multiple Methods for Detecting Apoptosis on the BD Accuri C6 Flow Cytometer. Introduction
March 212 Multiple Methods for Detecting Apoptosis on the BD Accuri C6 Flow Cytometer Contents 1 Introduction 2 Annexin V 4 JC-1 5 Caspase-3 6 APO-BrdU and APO-Direct Introduction Apoptosis (programmed
More informationab pdc Subset Phenotyping Kit
ab177772 pdc Subset Phenotyping Kit Instructions for Use A set of antibodies designed to identify pdcs and subsets of pdcs by multi-color flow cytometry. This product is for research use only and is not
More informationImmunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016
Immunological Techniques in Research and Clinical Medicine Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Antibodies Remarkable Tools for Research and Diagnosis You can make an antibody
More informationApplication Note. Assay Portability on the BD FACSVerse System. Summary. Maria Jaimes, Yibing Wang, Catherine McIntyre, and Dev Mittar
September Assay Portability on the BD FACSVerse System Maria Jaimes, Yibing Wang, Catherine McIntyre, and Dev Mittar Contents Summary Introduction 3 Objective 4 Methods 6 Results Discussion Conclusions
More informationReagent Titration for the ICS Assay
Purpose This standard operating procedure (SOP) describes how to titrate new lots of fluorochromeconjugated antibody reagents and the cell viability marker for use in the intracellular cytokine staining
More informationGS Analysis of Microarray Data
GS01 0163 Analysis of Microarray Data Keith Baggerly and Kevin Coombes Department of Bioinformatics and Computational Biology UT M. D. Anderson Cancer Center kabagg@mdanderson.org kcoombes@mdanderson.org
More informationMultiple layers of B cell memory with different effector functions. Ismail Dogan, Barbara Bertocci, Valérie Vilmont, Frédéric Delbos,
Multiple layers of B cell memory with different effector functions Ismail Dogan, Barbara Bertocci, Valérie Vilmont, Frédéric Delbos, Jérome Mégret, Sébastien Storck, Claude-Agnès Reynaud & Jean-Claude
More informationGenome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus α-hemolysin-mediated toxicity
Genome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus α-hemolysin-mediated toxicity Sebastian Virreira Winter, Arturo Zychlinsky and Bart W. Bardoel Department of Cellular
More informationIncorporating New, Bright Fluorochromes into Multicolor Panel Design
Incorporating New, Bright Fluorochromes into Multicolor Panel Design Maria C. Jaimes, MD Senior Staff Scientist BD Biosciences 23-14684-00 Overview Multicolor flow: successful application prerequisites
More informationFlow Cytometry - The Essentials
Flow Cytometry - The Essentials Pocket Guide to Flow Cytometry: 1. Know your Cytometer 2. Understanding Fluorescence and Fluorophores 3. Gating Process 4. Controls 5. Optimization 6. Panel Building 7.
More informationImmunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry *Akanni EO and # Palini A.
Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry *Akanni EO and # Palini A. * Department of Haematology & Blood Transfusion,College of Health Science, Ladoke Akintola University
More informationThese products are sold FOR RESEARCH USE ONLY; not for use in diagnostic procedures.
Minimal Residual Disease (MRD) testing by Next- Generation Sequencing (NGS) has become an important methodology demonstrating clear potential to optimize therapeutic management of lymphoproliferative diseases.
More informationThe measurement of telomere length was performed by the same method as in the previous study (11).
1 SUPPLEMENTAL DATA 2 3 METHODS 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Telomere length measurement by quantitative real-time PCR (q-pcr) The measurement of telomere length was performed
More informationProduct Datasheet. CD45 Antibody (MEM-28) NB Unit Size: 0.1 mg. Store at 4C. Do not freeze. Publications: 13
Product Datasheet CD45 Antibody (MEM-28) NB500-319 Unit Size: 0.1 mg Store at 4C. Do not freeze. Publications: 13 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/nb500-319
More informationSupplementary Figure 1. Effect of FRC-specific ablation of Myd88 on PP and mln organization.
Supplementary Figure 1 Effect of FRC-specific ablation of Myd88 on PP and mln organization. (a) PP numbers in 8 10 week old Cre-negative littermate (Ctrl) and Myd88-cKO mice (n = 11 mice; each dot represents
More informationQuality Control in Flow. Dr David Westerman Head of Haematopathology Peter MacCallum Cancer Centre
Quality Control in Flow Dr David Westerman Head of Haematopathology Peter MacCallum Cancer Centre Aims Quality Assurance Quality Control Literature In house competencies SHOT DATA 1996-2009 Ref: SHOT Annual
More informationTable S1. Antibodies and recombinant proteins used in this study
Table S1. Antibodies and recombinant proteins used in this study Labeled Antibody Clone Cat. no. Streptavidin-PerCP BD Biosciences 554064 Biotin anti-mouse CD25 7D4 BD Biosciences 553070 PE anti-mouse
More informationRuud Hulspas, Mike Keeney, Ben Hedley and Andrea Illingworth
Sponsored and reviewed by ICCS Quality and Standards Committee Title: Quality of Reagents Monoclonal Antibodies Written by: Date: March 6, 2018 Ruud Hulspas, Mike Keeney, Ben Hedley and Andrea Illingworth
More informationB lymphocytes in humans express ZAP-70 when activated in vivo
558 Giovanna Cutrona et al. Eur. J. Immunol. 2006. 36: 558 569 Cellular immune response B lymphocytes in humans express ZAP-70 when activated in vivo Giovanna Cutrona 1, Monica Colombo 1, Serena Matis
More informationProduct Datasheet. LMO2 Antibody NB Unit Size: 0.1 ml
Product Datasheet LMO2 Antibody NB110-83978 Unit Size: 0.1 ml Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Protocols, Publications, Related Products, Reviews,
More informationCFSE Cell Division Assay Kit
CFSE Cell Division Assay Kit Item No. 10009853 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION
More informationHuman skin punch biopsies were obtained under informed consent from normal healthy
SUPPLEMENTAL METHODS Acquisition of human skin specimens. Human skin punch biopsies were obtained under informed consent from normal healthy volunteers (n = 30) and psoriasis patients (n = 45) under a
More informationInhibiScreen Kinase Inhibitor Assay
InhibiScreen Kinase Inhibitor Assay Flow Cytometric assessment of efficacy of PI3Kγ, PI3Kδ, BTK and SYK pathway inhibitors using the measurement of basophil activation in human EDTA and Heparin Whole Blood.
More information2D gel Western blotting using antibodies against ubiquitin, SUMO and acetyl PTM
2D gel Western blotting using antibodies against ubiquitin, SUMO and acetyl PTM Nancy Kendrick, Jon Johansen & Matt Hoelter, Kendrick Labs Inc www.kendricklabs.com Talk Outline Significance Method description
More informationImmunogenicity. How to deal with? Nathalie Macé Sanofi, Biomarkers & Biological analyses Unit
Immunogenicity How to deal with? Nathalie Macé Sanofi, Biomarkers & Biological analyses Unit Club Phase I, 22 March 2016 1 Outline Introduction to immunogenicity Analytical challenges for immunogenicity
More informationQuality Control in polychromatic Flow Cytometry - EuroFlow interlaboratory standardization
IV. International Symposium Flow Cytometry/Molecular Biology HOSPITAL ISRAELITA ALBERT EINSTEIN São Paulo 2012 Quality Control in polychromatic Flow Cytometry - EuroFlow interlaboratory standardization
More informationSupplementary Figure. S1
Supplementary Figure. S1 Supplementary Figure S1. Correlation of phagocytic ability measured with YG and YO beads. Fresh human monocytes (2 10 6 /ml) were labelled with APC conjugated anti CD14 mab alone
More information11/19/2013. Janine Zankl FACS Core Facility 13. November Cellular Parameters. Cellular Parameters. Monocytes. Granulocytes.
DEPARTEMENT BIOZENTRUM Janine Zankl FACS Core Facility 13. November 2013 Cellular Parameters Granulocytes Monocytes Basophils Neutrophils Lymphocytes Eosinophils Cellular Parameters 1 What Is Flow Cytometry?
More informationA guide to selecting control, diluent and blocking reagents
Specializing in Secondary Antibodies and Conjugates A guide to selecting control, diluent and blocking reagents Optimize your experimental protocols with Jackson ImmunoResearch Secondary antibodies and
More informationA guide to selecting control, diluent and blocking reagents
Specializing in Secondary Antibodies and Conjugates A guide to selecting control, diluent and blocking reagents Optimize your experimental protocols with Jackson ImmunoResearch Secondary antibodies and
More informationAnatomy of a flow cytometer
Anatomy of a flow cytometer Fluidics Optics Electronics Cells in suspension flow in single-file through an illuminated volume where they scatter light and emit fluorescence that is collected, filtered,
More informationRecruitment of Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells
SUPPLEMENTARY FIGURES Recruitment of Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells Niklas Engels, Lars Morten König, Christina Heemann, Johannes
More informationOnline Materials for
Online Materials for Munc18-2/STXBP2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 (FHL5) and impairs cytotoxic granule exocytosis. Marjorie Côte 1,2,#, Mickaël M. Ménager 1,2,#,
More informationMayumi Egawa, Kaori Mukai, Soichiro Yoshikawa, Misako Iki, Naofumi Mukaida, Yohei Kawano, Yoshiyuki Minegishi, and Hajime Karasuyama
Immunity, Volume 38 Supplemental Information Inflammatory Monocytes Recruited to Allergic Skin Acquire an Anti-inflammatory M2 Phenotype via Basophil-Derived Interleukin-4 Mayumi Egawa, Kaori Mukai, Soichiro
More informationProduct Datasheet. CD31/PECAM-1 Antibody (C31.7) NBP mg. Unit Size: 0.1 mg. Store at 4C. Publications: 1
Product Datasheet CD31/PECAM-1 Antibody (C31.7) NBP2-15188-0.1mg Unit Size: 0.1 mg Store at 4C. Publications: 1 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/nbp2-15188
More informationEstablishing sirna assays in primary human peripheral blood lymphocytes
page 1 of 7 Establishing sirna assays in primary human peripheral blood lymphocytes This protocol is designed to establish sirna assays in primary human peripheral blood lymphocytes using the Nucleofector
More informationReagents and cell culture Mcl-1 gene expression: real-time quantitative RT-PCR In vitro PP2A phosphatase assay Detection of Mcl-1 in vivo
Reagents and cell culture Antibodies specific for caspase 3, PARP and GAPDH were purchased from Cell Signaling Technology Inc. (Beverly, MA). Caspase inhibitor z-vad-fmk and ROS scavenger N-acetyl-Lcysteine
More information(A-B) P2ry14 expression was assessed by (A) genotyping (upper arrow: WT; lower
Supplementary Figures S1. (A-B) P2ry14 expression was assessed by (A) genotyping (upper arrow: ; lower arrow: KO) and (B) q-pcr analysis with Lin- cells, The white vertical line in panel A indicates that
More informationApplication Note 18 RNA/DNA/Protein Sample Preparation METHODS AND MATERIALS INTRODUCTION
Application Note 18 /DNA/Protein Sample Preparation Sequential Purification of, DNA and Protein from a Single Sample using 's /DNA/Protein Purification Kit and Comparison to a Market B. Lam, PhD 1, C.
More informationNUCLEIC ACID PURIFICATION KITS FAST SIMPLE QUALITY CONVENIENT REPRODUCIBLE
NUCLEIC ACID PURIFICATION KITS FAST SIMPLE QUALITY CONVENIENT REPRODUCIBLE COMPANY PROFILE Since its founding in 1998,, Inc. has been at the forefront of nucleic acid purification by offering products
More informationSupplementary Information for
Supplementary Information for Siglec-7 Engagement by GBS -protein Suppresses Pyroptotic Cell Death of Natural Killer Cells Jerry J. Fong a,b, Chih-Ming Tsai a,b, Sudeshna Saha a,b, Victor Nizet a,c,d Ajit
More informationFlow Cytometric Preparation of CD34 + CD90 + Hematopoietic Stem Cells for Transplantation
Flow Cytometric Preparation of CD34 + CD9 + Hematopoietic Stem Cells for Transplantation B R YA N F OX S TA N F O R D L A B O R AT O R Y F O R C ELL & G ENE M E D I C I N E ISCT Regional Meeting Memphis,TN
More informationQuantification of Surface Antigens and Quantitative Flow Cytometry
5 Quantification of Surface Antigens and Quantitative Flow Cytometry Huai En Huang Chan, Iman Jilani, Richard Chang, and Maher Albitar Summary Measuring expression levels of cell surface antigens is important
More informationBD IntraSure Kit IVD. Cell fixation and permeabilization reagents. 50 tests per kit Catalog No
03/2015 23-8992-01 IVD BD IntraSure Kit Cell fixation and permeabilization reagents 50 tests per kit Catalog No. 641778 BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company.
More informationHistone H3K27 Methylation Antibody Panel Pack Base Catalog # C Component Size Shipping Temperature
Histone H3K27 Methylation Antibody Panel Pack Base Catalog # PACK CONTENTS Component Size Shipping Temperature Upon Receipt Checklist 3K27M Histone H3K27me1 (H3K27 Monomethyl) Polyclonal Antibody 25 µg
More informationFlow Cytometry Support Reagents
Excite and inspire Flow Cytometry Support Reagents Introduction Miltenyi Biotec is a leading supplier of flow cytometry products, offering one of the broadest ranges of antibodies, kits, assays, and support
More informationElectrophoresis and transfer
Electrophoresis and transfer Electrophoresis Cation = positively charged ion, it moves toward the cathode (-) Anion = negatively charged ion, it moves toward the anode (+) Amphoteric substance = can have
More informationIntroduction to Flow Cytometry. -- BD FACSCanto II TM. Daisy Kuo Assistant Product Manager BDBiosciences
Introduction to Flow Cytometry -- BD FACSCanto II TM Daisy Kuo Assistant Product Manager E-mail: daisy_kuo@bd.com BDBiosciences Outline Basic Concept of Flow Cytometry FACSCanto II System Introduction
More informationWhat you need to know before designing a panel
Design What you need to know before designing a panel For Research Use Only. Not for use in diagnostic or therapeutic procedures. Alexa Fluor is a registered trademark of Life Technologies Corporation.
More informationFlow-cytometry assessment of parasitemia in cell parasite co-culture assay using hydroethidine staining Western blotting RT-PCR
Flow-cytometry assessment of parasitemia in cell parasite co-culture assay using hydroethidine staining The capability of cells, either PBMC or purified T- cell lines, to inhibit parasite growth or merozoite
More informationExoCap TM Streptavidin Kit
CODE No. MEX-SA For Research Use Only. Not for use in diagnostic procedures. Printed June 28, 2016 Version 1.0 ExoCap TM Streptavidin Kit Exosome Isolation and Enrichment Kit PRODUCT DESCRIPTION ExoCap
More informationAnti-HB-EGF (Human) mab
Page 1 For Research Use Only. Not for use in diagnostic procedures. CODE No. D308-3 Anti-HB-EGF (Human) mab CLONALITY CLONE ISOTYPE QUANTITY SOURCE IMMUNOGEN FORMURATION STORAGE Monoclonal 3H4 Mouse IgG1
More informationSelecting Fluorochrome Conjugates for Maximum Sensitivity
2004 Wiley-Liss, Inc. Cytometry Part A 62A:169 173 (2004) Technical Primer Selecting Fluorochrome Conjugates for Maximum Sensitivity Holden T. Maecker,* Tom Frey, Laurel E. Nomura, and Joe Trotter BD Biosciences,
More informationStrategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
More informationThe RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The
SUPPLEMENTARY MATERIALS AND METHODS Real time quantitative PCR The RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The RT-qPCR was performed on the Applied Biosystems StepOne TM
More informationSupplementary Information to: Genome-wide Real-time in vivo Transcriptional Dynamics During Plasmodium falciparum. Blood-stage Development
Supplementary Information to: Genome-wide Real-time in vivo Transcriptional Dynamics During Plasmodium falciparum Blood-stage Development Painter et al. 1 of 8 Supplementary Figure 1: Supplementary Figure
More informationGene Sequence Annealing Temperature. Actin 5 : 5 -CATCACTATTGGCAACGAGC-3 60 C 3 : 5 -ACGCAGCTCAGTAACAGTCC-3 PCR product: 410 bp
Supporting Materials and Methods RT-PCR RT-PCR was performed as described in ref. 1 using the following oligonucleotides and PCR conditions: 2 min at 95 C, (20 s at 95 C, 20 s at the annealing temp, and
More informationHistone H3 Methylation Antibody Panel Pack I - Active Genes Base Catalog # C Component Size Shipping Temperature
Histone H3 Methylation Antibody Panel Pack I - Active Genes Base Catalog # PACK CONTENTS Component Size Shipping Temperature Upon Receipt Checklist 3K4D Histone H3K4me2 (H3K4 Dimethyl) Polyclonal Antibody
More informationA Brief Comparison Of The Various Techniques And Methods For Isolation Of Circulating Tumor Cells (CTC s)
1 of 5 A Brief Comparison Of The Various Techniques And Methods For Isolation Of Circulating Tumor Cells (CTC s) 11.15.13 This document is the result of many questions and concerns expressed over the past
More informationIdentification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer. Application Note
Identification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer Application Note Sylvie Veriac Valérie Perrone Madeleine Avon Abstract Agilent Equipment: 2100 bioanalyzer
More informationManaging Specimen Stability for Robust Flow Cytometric Clinical Biomarker Assays
Managing Specimen Stability for Robust Flow Cytometric Clinical Biomarker Assays Dianna Wu, Richard Wnek Molecular Biomarkers & Diagnostics Merck Co., Inc 2014 AAPS Annual Meeting San Diego, CA (Fluorescent
More informationClustalW algorithm. The alignment statistics are 96.9% for both pairwise identity and percent identical sites.
Identity Human Mouse Supplemental Figure 1. Amino acid sequence alignment of -MyHC. The alignment was created using the ClustalW algorithm. The alignment statistics are 96.9% for both pairwise identity
More informationProduct Datasheet. ATF3 Antibody NBP Unit Size: 0.1 ml. Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Product Datasheet ATF3 Antibody NBP1-02935 Unit Size: 0.1 ml Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Publications: 2 Protocols, Publications, Related Products,
More information1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?
1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please
More informationImmunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October
Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October APC Antigen processing (dendritic cells, MΦ et al.) Antigen "presentation" Ag/Ab complexes Antigenspecific triggering B T ANTIGEN Proliferation
More informationFlow Cytometry Immune Activation SOP
Flow Cytometry Immune Activation SOP Purpose This SOP standardizes the procedure for measuring immune activation of T cells using flow cytometry in ACTG Immunology Laboratories. Materials 1. 12x75mm flow
More informationFor Research Use Only. Not for use in diagnostic procedures. Anti-NRF2 mab
Page 1 For Research Use Only. Not for use in diagnostic procedures. Anti-NRF2 mab CODE No. M200-3 CLONALITY CLONE ISOTYPE QUANTITY SOURCE IMMUNOGEN FORMURATION STORAGE Monoclonal 1F2 Mouse IgG1 100 L,
More informationSupplementary Figure 1. Antigens generated for mab development (a) K9M1P1-mIgG and hgh-k9m1p1 antigen (~37 kda) expression verified by western blot
Supplementary Figure 1. Antigens generated for mab development (a) K9M1P1-mIgG and hgh-k9m1p1 antigen (~37 kda) expression verified by western blot (vector: ~25 kda). (b) Silver staining was used to assess
More informationExoCap TM Streptavidin Kit
CODE No. MEX-SA For Research Use Only. Not for use in diagnostic procedures. Printed July 5, 2017 Version 2.0 ExoCap TM Streptavidin Kit Exosome Isolation and Enrichment Kit PRODUCT DESCRIPTION ExoCap
More informationSpecialty Lab Services. Deep science at scale
Specialty Lab Services Deep science at scale Advancing biomarker research Our broad expertise and global laboratory footprint deliver deep science at scale Specialty assays drive insight into preclinical
More informationPERFECT-COUNT MICROSPHERES
PERFECT-COUNT MICROSPHERES Perfect-Count Microspheres-Product code PCB-100 for 100 tests Introduction In recent years, the determination of absolute cell counts has been shown to be relevant in different
More informationWVU FLOW CYTOMETRY & SINGLE CELL CORE FACILITY
WVU FLOW CYTOMETRY & SINGLE CELL CORE FACILITY Newsletter Volume 5, issue 1 July 2018 Finding and Validating Antibodies Part 1 Inside this Issue 1-2 Finding and Validating Antibodies Part 1 3 4 Flow Cytometers
More informationAntigen-antibody reactions with labeled reagents
Antigen-antibody reactions with labeled reagents Department of Immunology Faculty of Medicine University of Belgrade ANTIGEN ANTIBODY REACTIONS WITH LABELED REAGENTS Enzyme immunoassay Radioimmunoassay
More informationProduct Datasheet. AKT1 [p Ser473] Antibody NB Unit Size: 0.1 mg. Store at -20C. Avoid freeze-thaw cycles. Publications: 3
Product Datasheet AKT1 [p Ser473] Antibody NB600-590 Unit Size: 0.1 mg Store at -20C. Avoid freeze-thaw cycles. Publications: 3 Protocols, Publications, Related Products, Reviews, Research Tools and Images
More informationThe Immunogenicity of Protein Therapeutics: time to get personal?
The Immunogenicity of Protein Therapeutics: time to get personal? Zuben E Sauna Division of Hematology, Office of Blood Research and Review (OBRR) Center for Biologics Evaluation and Research (CBER) Food
More informationImmunohistochemistry guide
Immunohistochemistry guide overview immunohistochemistry Overview Immunohistochemistry is a laboratory technique utilized for the visual detection of antigens in tissue. When working with cells this technique
More informationTECHNICAL BULLETIN. QUANTUM SIMPLY CELLULAR KIT Product Numbers QSC-20 AND QSC-100 Storage Temperature 2-8 C. Do Not Freeze
QUANTUM SIMPLY CELLULAR KIT Product Numbers QSC-20 AND QSC-100 Storage Temperature 2-8 C. Do Not Freeze TECHNICAL BULLETIN Product Description The Quantum Simply Cellular Kit provides a convenient method
More informationProduct Datasheet. Histone H4 [Dimethyl Lys20] Antibody NB SS. Unit Size: mg
Product Datasheet Histone H4 [Dimethyl Lys20] Antibody NB21-2089SS Unit Size: 0.025 mg Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Protocols, Publications, Related
More informationIGF-1 promotes the development and cytotoxic activity of human NK cells regulated
Supplementary Information for IGF-1 promotes the development and cytotoxic activity of human NK cells regulated by mir-483-3p Fang Ni 1, 2, Rui Sun 1, Binqing Fu 1, Fuyan Wang 1, Chuang Guo 1, Zhigang
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Do not freeze. Store at 2-8 C. Do not freeze. Store at 2-8 C.
This document is available at www.stemcell.com/pis Positive Selection Catalog #7896 EasySep Human Cord Blood CD3 Positive For processing 000 ml of cord blood Description Isolate highly purified CD3+ cells
More informationAntibodies to Animal Cells and Serum Proteins
ANTIBODIES TO ANIMAL CELLS AND SERUM PROTEINS Antibodies to Animal Cells and Serum Proteins Antibodies to Animal Cellular Antigens Antibodies to Mouse Brain Antibodies to Animal Serum Proteins INTERNATIONAL
More information1. Cross-linking and cell harvesting
ChIP is a powerful tool that allows the specific matching of proteins or histone modifications to regions of the genome. Chromatin is isolated and antibodies to the antigen of interest are used to determine
More information7-amino actinomycin D (7ADD) was added to all samples 10 minutes prior to analysis on the flow cytometer in order to gate 7AAD viable cells.
Antibody staining for Ho uptake analyses For HSC staining, 10 7 BM cells from Ho perfused mice were stained with biotinylated lineage antibodies (CD3, CD5, B220, CD11b, Gr-1, CD41, Ter119), anti Sca-1-PECY7,
More informationPage 1 of 2. Product Information Contents: ebioscience BrdU Staining Kit for Flow Cytometry FITC
Page 1 of 2 ebioscience BrdU Staining Kit for Flow Cytometry FITC Also known as: 5-bromodeoxyuridine RUO: For Research Use Only. Not for use in diagnostic procedures. Anti-CD3/CD28-stimulated mouse splenocytes
More informationTargeted Sequencing of Leukemia-Associated Genes Using 454 Sequencing Systems
Sequencing Application Note March 2012 Targeted Sequencing of Leukemia-Associated Genes Using 454 Sequencing Systems GS GType TET2/CBL/KRAS and RUNX1 Primer Sets for the GS Junior and GS FLX Systems. Introduction
More information